SCHIZOPHRENIA

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug (PubMed)

Cannabidiol as a potential treatment for psychosis (PubMed)

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (PubMed)

Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (PubMed)

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation (PubMed)

Peripheral endocannabinoid system dysregulation in first-episode psychosis (PubMed)

Cannabinoids and schizophrenia: Therapeutic prospects (PubMed)

Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies (PubMed)

Cannabidiol monotherapy for treatment-resistant schizophrenia (PubMed)

Cannabis with high cannabidiol content is associated with fewer psychotic experiences (PubMed)

Marijuana compound treats schizophrenia with few side effects: Clinical trial (Time)

Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia? (PubMed)